4//SEC Filing
BUTLER MARK S 4
Accession 0001181431-08-054920
CIK 0000854222other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:56 PM ET
Size
13.3 KB
Accession
0001181431-08-054920
Insider Transaction Report
Form 4
BUTLER MARK S
Executive Vice President
Transactions
- Disposition to Issuer
Common Stock, $.001 par value
2008-09-26$2.88/sh−1,000$2,880→ 82,747 total - Award
Common Stock, $.001 par value
2008-09-26$2.38/sh+5,000$11,875→ 85,547 total - Disposition to Issuer
Common Stock, $.001 par value
2008-09-26$2.87/sh−1,200$3,444→ 81,547 total - Exercise/Conversion
Employee Stock option (right to buy)
2008-09-26$2.38/sh−5,000$11,875→ 349,000 totalExercise: $2.38From: 2001-04-05Exp: 2010-04-05→ Common Stock, $.001 par value (5,000 underlying) - Disposition to Issuer
Common Stock, $.001 par value
2008-09-26$2.89/sh−1,800$5,202→ 83,747 total
Footnotes (3)
- [F1]Represents exercise of stock option granted pursuant to the Company's 1994 Long-term Incentive Plan. This stock option is a portion of a stock option award that had incremental vesting and became fully exercisble on April 5, 2001.
- [F2]Represents shares acquired from exercise of stock options granted pursuant to the Company's 1994 Long-term Incentive Plan.
- [F3]Represents sale pursuant to a 10b5-1 Plan of common stock received following exercise of stock option as discussed in footnote 2.
Documents
Issuer
INDEVUS PHARMACEUTICALS INC
CIK 0000854222
Entity typeother
Related Parties
1- filerCIK 0001244161
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:56 PM ET
- Size
- 13.3 KB